$1.68 Million is the total value of Artal Group S.A.'s 120 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 50.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS INC | $218,161 | +27.2% | 89,778,234 | 0.0% | 12.96% | +35.4% | |
BGNE | Sell | BEIGENE LTDsponsored adr | $108,053 | -18.1% | 501,335 | -16.4% | 6.42% | -12.8% |
APLS | Buy | APELLIS PHARMACEUTICALS INC | $80,228 | +72.4% | 1,216,312 | +35.1% | 4.77% | +83.5% |
SRRK | Buy | SCHOLAR ROCK HLDG CORP | $72,224 | -11.1% | 9,027,950 | +0.5% | 4.29% | -5.4% |
MORF | Sell | MORPHIC HLDG INC | $68,277 | +18.7% | 1,813,949 | -15.6% | 4.06% | +26.4% |
WW | WW INTL INC | $61,051 | +6.7% | 14,818,300 | 0.0% | 3.63% | +13.6% | |
MRTX | Sell | MIRATI THERAPEUTICS INC | $57,172 | -31.2% | 1,537,709 | -16.1% | 3.40% | -26.7% |
KYMR | Sell | KYMERA THERAPEUTICS INC | $53,492 | +7.2% | 1,805,346 | -9.7% | 3.18% | +14.1% |
CYTK | Buy | CYTOKINETICS INC | $48,106 | +5.0% | 1,367,023 | +36.7% | 2.86% | +11.8% |
SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $46,779 | -10.1% | 1,817,349 | -9.1% | 2.78% | -4.3% |
CERE | Buy | CEREVEL THERAPEUTICS HLDNG I | $46,694 | -22.1% | 1,914,466 | +0.8% | 2.78% | -17.0% |
RVMD | Buy | REVOLUTION MEDICINES INC | $44,858 | +88.3% | 2,070,988 | +107.1% | 2.66% | +100.4% |
FOLD | Sell | AMICUS THERAPEUTICS INC | $39,108 | -19.9% | 3,526,407 | -11.8% | 2.32% | -14.7% |
IGMS | Buy | IGM BIOSCIENCES INC | $34,487 | -17.2% | 2,509,972 | +2.4% | 2.05% | -11.9% |
KRYS | Buy | KRYSTAL BIOTECH INC | $32,991 | +4.1% | 412,082 | +3.0% | 1.96% | +10.8% |
SAGE | SAGE THERAPEUTICS INC | $31,470 | +10.0% | 750,000 | 0.0% | 1.87% | +17.1% | |
RLAY | Buy | RELAY THERAPEUTICS INC | $27,567 | +26.8% | 1,673,743 | +15.1% | 1.64% | +35.0% |
SE | Buy | SEA LTDsponsored ads | $26,181 | +191.7% | 302,500 | +75.4% | 1.56% | +210.6% |
AGEN | Buy | AGENUS INC | $23,759 | -31.7% | 15,631,235 | +7.8% | 1.41% | -27.3% |
ALVR | ALLOVIR INC | $21,974 | -23.2% | 5,577,167 | 0.0% | 1.31% | -18.2% | |
VIGIL NEUROSCIENCE INC | $21,962 | -21.7% | 2,243,352 | 0.0% | 1.30% | -16.6% | ||
KURA | Buy | KURA ONCOLOGY INC | $21,012 | -0.4% | 1,718,056 | +1.1% | 1.25% | +6.0% |
DNLI | Buy | DENALI THERAPEUTICS INC | $18,499 | -16.9% | 802,899 | +0.4% | 1.10% | -11.5% |
SDGR | SCHRODINGER INC | $18,431 | +40.9% | 700,000 | 0.0% | 1.10% | +50.0% | |
SEER | SEER INC | $18,335 | -33.4% | 4,750,000 | 0.0% | 1.09% | -29.2% | |
New | VENTYX BIOSCIENCES INC | $17,950 | – | 535,812 | +100.0% | 1.07% | – | |
Buy | OMEGA THERAPEUTICS INC | $15,274 | +17.7% | 2,533,045 | +11.4% | 0.91% | +25.2% | |
VOR | Sell | VOR BIOPHARMA INC | $15,025 | -21.4% | 2,792,805 | -2.9% | 0.89% | -16.3% |
FATE | FATE THERAPEUTICS INC | $14,820 | -43.5% | 2,600,000 | 0.0% | 0.88% | -39.8% | |
Buy | ERASCA INC | $14,211 | -30.0% | 4,721,194 | +0.2% | 0.84% | -25.5% | |
RXDX | New | PROMETHEUS BIOSCIENCES INC | $13,067 | – | 121,756 | +100.0% | 0.78% | – |
WVE | WAVE LIFE SCIENCES LTD | $12,990 | -38.1% | 3,000,000 | 0.0% | 0.77% | -34.1% | |
VRDN | New | VIRIDIAN THERAPEUTICS INC | $12,847 | – | 504,978 | +100.0% | 0.76% | – |
GBIO | GENERATION BIO CO | $12,101 | +9.4% | 2,814,191 | 0.0% | 0.72% | +16.5% | |
GERN | New | GERON CORP | $12,078 | – | 5,565,889 | +100.0% | 0.72% | – |
TVTX | Buy | TRAVERE THERAPEUTICS INC | $11,510 | +9.5% | 511,784 | +2.4% | 0.68% | +16.5% |
NTRA | NATERA INC | $11,104 | +38.2% | 200,000 | 0.0% | 0.66% | +47.3% | |
AUPH | AURINIA PHARMACEUTICALS INC | $10,960 | +153.7% | 1,000,000 | 0.0% | 0.65% | +170.1% | |
GLYC | New | GLYCOMIMETICS INC | $10,822 | – | 8,589,064 | +100.0% | 0.64% | – |
FHTX | FOGHORN THERAPEUTICS INC | $10,668 | -2.8% | 1,720,720 | 0.0% | 0.63% | +3.4% | |
NTLA | Buy | INTELLIA THERAPEUTICS INC | $10,289 | +7.2% | 276,077 | +0.4% | 0.61% | +14.0% |
ALPN | ALPINE IMMUNE SCIENCES INC | $9,210 | +5.0% | 1,193,030 | 0.0% | 0.55% | +11.9% | |
ARAV | ARAVIVE INC | $9,145 | +51.5% | 4,572,515 | 0.0% | 0.54% | +61.1% | |
MRSN | Buy | MERSANA THERAPEUTICS INC | $9,107 | -29.4% | 2,215,788 | +0.7% | 0.54% | -24.9% |
REPL | Sell | REPLIMUNE GROUP INC | $8,830 | -53.6% | 500,000 | -28.6% | 0.52% | -50.6% |
BBIO | Buy | BRIDGEBIO PHARMA INC | $8,290 | +335.2% | 500,000 | +100.0% | 0.49% | +365.1% |
RNA | Buy | AVIDITY BIOSCIENCES INC | $7,859 | -29.2% | 511,962 | +2.4% | 0.47% | -24.6% |
TGTX | New | TG THERAPEUTICS INC | $7,691 | – | 511,389 | +100.0% | 0.46% | – |
New | 2SEVENTY BIO INC | $7,650 | – | 750,000 | +100.0% | 0.46% | – | |
ETNB | Buy | 89BIO INC | $7,615 | +49.5% | 500,000 | +25.0% | 0.45% | +59.2% |
FUSN | Buy | FUSION PHARMACEUTICALS INC | $7,446 | +215.1% | 1,975,000 | +163.3% | 0.44% | +234.8% |
RPTX | REPARE THERAPEUTICS INC | $6,888 | -33.1% | 700,000 | 0.0% | 0.41% | -28.9% | |
SELB | SELECTA BIOSCIENCES INC | $6,788 | +23.0% | 4,883,200 | 0.0% | 0.40% | +30.8% | |
PLRX | New | PLIANT THERAPEUTICS INC | $6,785 | – | 255,085 | +100.0% | 0.40% | – |
OVID | OVID THERAPEUTICS INC | $6,450 | +38.7% | 2,500,000 | 0.0% | 0.38% | +47.3% | |
AMAM | Sell | AMBRX BIOPHARMA INCsponsored ads | $6,264 | +28.2% | 702,291 | -67.4% | 0.37% | +36.3% |
DYN | Buy | DYNE THERAPEUTICS INC | $6,136 | +0.8% | 532,609 | +1.4% | 0.36% | +7.4% |
KDNY | New | CHINOOK THERAPEUTICS INC | $5,989 | – | 258,687 | +100.0% | 0.36% | – |
ITOS | ITEOS THERAPEUTICS INC | $5,444 | -30.3% | 400,000 | 0.0% | 0.32% | -25.9% | |
IKNA | IKENA ONCOLOGY INC | $5,346 | +29.7% | 1,549,513 | 0.0% | 0.32% | +38.3% | |
BEKE | Sell | KE HLDGS INCsponsored ads | $5,181 | -25.8% | 275,000 | -45.0% | 0.31% | -21.0% |
VKTX | New | VIKING THERAPEUTICS INC | $4,995 | – | 300,000 | +100.0% | 0.30% | – |
New | ROIVANT SCIENCES LTD | $4,428 | – | 600,000 | +100.0% | 0.26% | – | |
VERV | VERVE THERAPEUTICS INC | $4,326 | -25.5% | 300,000 | 0.0% | 0.26% | -20.7% | |
SOLID BIOSCIENCES INC | $4,310 | -11.9% | 909,219 | 0.0% | 0.26% | -6.2% | ||
Buy | SYROS PHARMACEUTICALS INC | $3,940 | -25.0% | 1,475,744 | +0.8% | 0.23% | -20.1% | |
ANNX | New | ANNEXON INC | $3,920 | – | 1,018,303 | +100.0% | 0.23% | – |
PORTAGE FINTECH ACQUISITN CO | $3,891 | +1.9% | 380,000 | 0.0% | 0.23% | +8.5% | ||
GOSS | Sell | GOSSAMER BIO INC | $3,815 | -45.8% | 3,028,171 | -6.7% | 0.23% | -42.2% |
NBTX | NANOBIOTIXsponsored ads | $3,525 | -4.0% | 1,000,000 | 0.0% | 0.21% | +2.0% | |
SLN | New | SILENCE THERAPEUTICS PLCads | $3,131 | – | 505,074 | +100.0% | 0.19% | – |
BDTX | BLACK DIAMOND THERAPEUTICS I | $3,112 | +5.0% | 1,646,517 | 0.0% | 0.18% | +12.1% | |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,108 | – | 31,967 | +100.0% | 0.18% | – |
IMAB | I MABsponsored ads | $2,941 | -17.2% | 850,000 | 0.0% | 0.18% | -11.6% | |
TSM | New | TAIWAN SEMICONDUCTOR MFG LTDsponsored ads | $2,791 | – | 30,000 | +100.0% | 0.17% | – |
CGEM | CULLINAN ONCOLOGY INC | $2,558 | -3.0% | 250,000 | 0.0% | 0.15% | +3.4% | |
ALXO | ALX ONCOLOGY HLDGS INC | $2,260 | -59.9% | 500,000 | 0.0% | 0.13% | -57.5% | |
KRON | KRONOS BIO INC | $2,253 | -9.9% | 1,542,954 | 0.0% | 0.13% | -4.3% | |
ACHL | ACHILLES THERAPEUTICS PLCsponsored ads | $2,160 | +6.4% | 2,255,375 | 0.0% | 0.13% | +13.3% | |
STOK | STOKE THERAPEUTICS INC | $2,083 | -9.7% | 250,000 | 0.0% | 0.12% | -3.9% | |
IMUX | IMMUNIC INC | $1,899 | +6.4% | 1,274,713 | 0.0% | 0.11% | +13.0% | |
New | STRUCTURE THERAPEUTICS INCsponsored ads | $1,784 | – | 75,000 | +100.0% | 0.11% | – | |
TALS | Sell | TALARIS THERAPEUTICS INC | $1,719 | -18.4% | 914,262 | -55.7% | 0.10% | -13.6% |
ME | 23ANDME HOLDING CO | $1,507 | +5.5% | 661,009 | 0.0% | 0.09% | +12.5% | |
ADAG | ADAGENE INCads | $1,450 | +9.4% | 1,000,000 | 0.0% | 0.09% | +16.2% | |
XILIO THERAPEUTICS INC | $1,427 | +17.8% | 450,000 | 0.0% | 0.08% | +25.0% | ||
HOOK | HOOKIPA PHARMA INC | $1,361 | -9.1% | 1,849,616 | 0.0% | 0.08% | -3.6% | |
LPTX | LEAP THERAPEUTICS INC | $1,360 | -24.4% | 4,000,000 | 0.0% | 0.08% | -19.0% | |
SANA | SANA BIOTECHNOLOGY INC | $1,308 | -17.2% | 400,000 | 0.0% | 0.08% | -11.4% | |
CYCN | CYCLERION THERAPEUTICS INC | $1,206 | -33.8% | 2,779,122 | 0.0% | 0.07% | -29.4% | |
IRWD | IRONWOOD PHARMACEUTICALS INC | $1,163 | -15.0% | 110,532 | 0.0% | 0.07% | -9.2% | |
TSHA | TAYSHA GENE THERAPIES INC | $1,149 | -64.7% | 1,440,882 | 0.0% | 0.07% | -62.6% | |
TCRR | TCR2 THERAPEUTICS INC | $1,125 | +50.2% | 750,000 | 0.0% | 0.07% | +59.5% | |
SQZ | SQZ BIOTECHNOLOGIES CO | $900 | -24.3% | 1,606,309 | 0.0% | 0.05% | -19.7% | |
CRIS | CURIS INC | $775 | +8.4% | 1,300,000 | 0.0% | 0.05% | +15.0% | |
KNTE | KINNATE BIOPHARMA INC | $781 | +2.4% | 125,000 | 0.0% | 0.05% | +7.0% | |
HARP | HARPOON THERAPEUTICS INC | $744 | +2.5% | 1,000,000 | 0.0% | 0.04% | +7.3% | |
UTHR | New | UNITED THERAPEUTICS CORP | $735 | – | 3,281 | +100.0% | 0.04% | – |
ARWR | New | ARROWHEAD PHARMACEUTICALS IN | $665 | – | 26,173 | +100.0% | 0.04% | – |
BCRX | New | BIOCRYST PHARMACEUTICALS INC | $566 | – | 67,909 | +100.0% | 0.03% | – |
MINK THERAPEUTICS INC | $549 | -27.4% | 289,588 | 0.0% | 0.03% | -21.4% | ||
CARIBOU BIOSCIENCES INC | $559 | -15.6% | 105,347 | 0.0% | 0.03% | -10.8% | ||
MTCR | METACRINE INC | $528 | +27.5% | 924,898 | 0.0% | 0.03% | +34.8% | |
ARVN | New | ARVINAS INC | $495 | – | 18,108 | +100.0% | 0.03% | – |
CRVS | CORVUS PHARMACEUTICALS INC | $455 | +7.1% | 500,000 | 0.0% | 0.03% | +12.5% | |
HIPPO HLDGS INC | $390 | +19.6% | 24,000 | 0.0% | 0.02% | +27.8% | ||
BEAM | New | BEAM THERAPEUTICS INC | $336 | – | 10,975 | +100.0% | 0.02% | – |
LVTX | LAVA THERAPEUTICS NV | $332 | -52.6% | 200,000 | 0.0% | 0.02% | -48.7% | |
KRTX | Sell | KARUNA THERAPEUTICS INC | $317 | -98.9% | 1,747 | -98.8% | 0.02% | -98.8% |
BAC | New | BANK AMERICA CORP | $229 | – | 8,000 | +100.0% | 0.01% | – |
AIG | New | AMERICAN INTL GROUP INC | $201 | – | 4,000 | +100.0% | 0.01% | – |
CFG | New | CITIZENS FINL GROUP INC | $152 | – | 5,000 | +100.0% | 0.01% | – |
PRTA | New | PROTHENA CORP PLC | $133 | – | 2,746 | +100.0% | 0.01% | – |
New | DICE THERAPEUTICS INC | $124 | – | 4,318 | +100.0% | 0.01% | – | |
KINETA INC | $103 | -47.7% | 31,055 | 0.0% | 0.01% | -45.5% | ||
SENTI BIOSCIENCES INC | $66 | -15.4% | 55,555 | 0.0% | 0.00% | 0.0% | ||
RUBY | RUBIUS THERAPEUTICS INC | $44 | -87.7% | 2,042,666 | 0.0% | 0.00% | -85.0% | |
New | CONTRAFECT CORP | $34 | – | 18,750 | +100.0% | 0.00% | – | |
CDAK | Exit | CODIAK BIOSCIENCES INC | $0 | – | -200,000 | -100.0% | -0.00% | – |
CFRX | Exit | CONTRAFECT CORP | $0 | – | -1,500,000 | -100.0% | -0.01% | – |
CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -224,675 | -100.0% | -0.01% | – |
MEIP | Exit | MEI PHARMA INC | $0 | – | -1,000,000 | -100.0% | -0.01% | – |
NEXI | Exit | NEXIMMUNE INC | $0 | – | -1,200,000 | -100.0% | -0.02% | – |
TIL | Exit | INSTIL BIO INC | $0 | – | -450,000 | -100.0% | -0.02% | – |
PANW | Exit | PALO ALTO NETWORKS INC | $0 | – | -2,000 | -100.0% | -0.02% | – |
APLT | Exit | APPLIED THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.02% | – |
OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -260,500 | -100.0% | -0.04% | – |
ORTX | Exit | ORCHARD THERAPEUTICS PLCsponsored ads | $0 | – | -1,803,858 | -100.0% | -0.04% | – |
TSLA | Exit | TESLA INC | $0 | – | -6,300 | -100.0% | -0.04% | – |
IGMS | Exit | IGM BIOSCIENCES INCcall | $0 | – | -50,000 | -100.0% | -0.05% | – |
CRDF | Exit | CARDIFF ONCOLOGY INC | $0 | – | -750,000 | -100.0% | -0.06% | – |
MREO | Exit | MEREO BIOPHARMA GROUP PLCsponsored ads | $0 | – | -1,500,000 | -100.0% | -0.06% | – |
APTX | Exit | APTINYX INC | $0 | – | -6,116,493 | -100.0% | -0.10% | – |
IMMP | Exit | IMMUTEP LTDsponsored ads | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.11% | – |
ACIU | Exit | AC IMMUNE SA | $0 | – | -1,000,000 | -100.0% | -0.11% | – |
GRPH | Exit | GRAPHITE BIO INC | $0 | – | -700,000 | -100.0% | -0.13% | – |
ORIC | Exit | ORIC PHARMACEUTICALS INC | $0 | – | -400,000 | -100.0% | -0.13% | – |
LYEL | Exit | LYELL IMMUNOPHARMA INC | $0 | – | -700,000 | -100.0% | -0.14% | – |
OTLY | Exit | OATLY GROUP ABsponsored ads | $0 | – | -1,500,000 | -100.0% | -0.15% | – |
PRAX | Exit | PRAXIS PRECISION MEDICINES I | $0 | – | -1,200,000 | -100.0% | -0.16% | – |
Exit | EXSCIENTIA PLCads | $0 | – | -550,000 | -100.0% | -0.16% | – | |
Exit | MIRION TECHNOLOGIES INC | $0 | – | -500,000 | -100.0% | -0.18% | – | |
ZYME | Exit | ZYMEWORKS INC | $0 | – | -450,000 | -100.0% | -0.20% | – |
Exit | AURA BIOSCIENCES INC | $0 | – | -410,000 | -100.0% | -0.24% | – | |
Exit | EQRX INC | $0 | – | -2,000,000 | -100.0% | -0.28% | – | |
GRTS | Exit | GRITSTONE BIO INC | $0 | – | -1,856,194 | -100.0% | -0.36% | – |
Exit | BIOHAVEN LTD | $0 | – | -500,000 | -100.0% | -0.39% | – | |
RXRX | Exit | RECURSION PHARMACEUTICALS INcl a | $0 | – | -960,204 | -100.0% | -0.41% | – |
EVTCY | Exit | EVOTEC AGsponsored ads | $0 | – | -1,149,425 | -100.0% | -0.52% | – |
INSM | Exit | INSMED INC | $0 | – | -500,000 | -100.0% | -0.56% | – |
BEKE | Exit | KE HLDGS INCcall | $0 | – | -800,000 | -100.0% | -0.62% | – |
ISEE | Exit | IVERIC BIO INC | $0 | – | -1,000,000 | -100.0% | -1.20% | – |
BGNE | Exit | BEIGENE LTDcall | $0 | – | -100,000 | -100.0% | -1.23% | – |
MRTX | Exit | MIRATI THERAPEUTICS INCcall | $0 | – | -500,000 | -100.0% | -1.26% | – |
BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -3,700,000 | -100.0% | -1.70% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-12
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AGENUS INC | 42 | Q3 2023 | 1.9% |
IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
BEIGENE LTD | 28 | Q3 2023 | 7.4% |
BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-25 |
4 | 2024-03-13 |
4 | 2024-02-29 |
13F-HR | 2024-02-09 |
13F-HR | 2023-11-13 |
4 | 2023-10-16 |
13F-HR | 2023-08-11 |
4 | 2023-06-22 |
3 | 2023-06-15 |
4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.